Depression in Alzheimer's disease: the effect of serotonin receptor gene variation

Am J Med Genet B Neuropsychiatr Genet. 2003 May 15;119B(1):40-3. doi: 10.1002/ajmg.b.10068.

Abstract

This study investigated possible associations between selected polymorphisms in the serotonin receptor genes, 5-HT2A and 5-HT2C, with the presence of co-morbid depressive illness at baseline in a community based cohort of 158 patients with late onset patients with Alzheimer's disease (AD). An association was found between the presence of major depressive illness at baseline and both the 5-HT2A and 5-HT2C polymorphisms. Specifically, homozygous carriers of the 5-HT2A C102 allele were five times more likely to have major depressive illness than heterozygotes. In addition, homozygous or hemizygous carriers of the 5-HT2C Ser allele were 12 times more likely to have major depressive illness than homozygous or hemizygous carriers of the 5-HT2C Cys allele.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / complications*
  • Alzheimer Disease / genetics
  • Cohort Studies
  • Comorbidity
  • Depression / etiology
  • Depression / genetics*
  • Female
  • Genotype
  • Heterozygote
  • Homozygote
  • Humans
  • Male
  • Odds Ratio
  • Polymorphism, Genetic*
  • Receptor, Serotonin, 5-HT2A / genetics
  • Receptor, Serotonin, 5-HT2C / genetics
  • Receptors, Serotonin, 5-HT2 / genetics*

Substances

  • Receptor, Serotonin, 5-HT2A
  • Receptor, Serotonin, 5-HT2C
  • Receptors, Serotonin, 5-HT2